In addition, we refer readers to Addendum D1 to this final rule with comment period for the status indicator meanings for all codes reported under the OPPS
FDA Category 2 status AOD-9604 was previously nominated for inclusion under FDA's Category 2 list (substances proposed for compounding under research/evaluation)
Cagrilintide 0.3-4.5 mg vs liraglutide 3 mg/day
The influence of race and ethnicity on the biology of cancer
Broad Melanocortin Activity: It activates multiple melanocortin receptors ( MC1R, MC3R, MC4R, MC5R ), which supports research across pigmentation, neuroendocrine, and metabolic signaling pathways
Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances